Walleye Capital’s Pulmonx LUNG Stock Holding History

Walleye Capital’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$219K	Buy	+114,399	New	+$216K	﹤0.01%	4746
2023 Q4	–	Sell	-372,290	Closed	-$3.85M	–	5271
2023 Q3	$3.85M	Buy	+372,290	New	+$4.31M	0.01%	1227
2022 Q4	–	Sell	-27,559	Closed	-$459K	–	3443
2022 Q3	$459K	Sell	27,559 -6,498	-19%	-$120K	0.01%	1539
2022 Q2	$501K	Buy	+34,057	New	+$702K	0.01%	1027
2021 Q4	–	Sell	-8,154	Closed	-$293K	–	2221
2021 Q3	$293K	Buy	+8,154	New	+$321K	0.01%	1023

Other funds holding LUNG

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Walleye Capital's LUNG Position: Q3 2026 in Review

Walleye Capital opened a new position in Pulmonx (LUNG) in Q3 2026: 114,399 shares worth $219K. The stake represents ﹤0.01% of the portfolio and ranks #4746 among its holdings. This is a return to the name: Walleye Capital previously reported a position in LUNG as recently as Q3 2023.

Walleye Capital first reported a position in LUNG in Q3 2021 and has held it in 5 quarters since. The position peaked at $3.85M in Q3 2023. 72 funds tracked by Wall St. Rank hold LUNG as of Q3 2026.

Walleye Capital held 114,399 shares of Pulmonx worth $219K as of Q3 2026.
Pulmonx was a new Walleye Capital position in Q3 2026.
Pulmonx made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #4746 holding.
Walleye Capital first reported a position in Pulmonx in Q3 2021 and has held it in 5 quarters since.
Walleye Capital's Pulmonx position peaked at $3.85M in Q3 2023.
72 funds tracked by Wall St. Rank held Pulmonx as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.